Susquehanna International Group, LLP Mersana Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.23 - $2.25 $13,284 - $24,300	-10,800 Reduced 22.36%	37,500 $70,000
Q2 2024 Aug 15, 2024	BUY	$2.0 - $4.45 $1,800 - $4,005	900 Added 1.9%	48,300 $97,000
Q1 2024 May 07, 2024	BUY	$2.16 - $5.94 $2,160 - $5,940	1,000 Added 2.16%	47,400 $212,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $96,681 - $203,814	-87,100 Reduced 65.24%	46,400 $107,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $674,690 - $2.49 Million	-636,500 Reduced 82.66%	133,500 $169,000
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $1.91 Million - $5.92 Million	620,400 Added 414.71%	770,000 $2.53 Million
Q1 2023 May 16, 2023	BUY	$4.0 - $7.02 $598,400 - $1.05 Million	149,600 New	149,600 $614,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $893,664 - $1.51 Million	-104,400 Reduced 81.31%	24,000 $226,000
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $1.65 Million - $2.86 Million	108,000 Added 529.41%	128,400 $2.08 Million
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $166,716 - $273,141	-9,900 Reduced 32.67%	20,400 $543,000
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $301,320 - $478,020	18,600 Added 158.97%	30,300 $564,000
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $61,308 - $273,780	11,700 New	11,700 $274,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $201M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.